27 April, 2017 by The TZ Newswire Staff Comments Off on Under Armour: Bulls Need a Reality Check
Under Armour: Bulls Need a Reality Check
Apparel and footwear company Under Armour (NYSE: UA)(NYSE: UAA) has grown at an impressive pace over the past decade, all while maintaining solid profitability. Under Armour produced $4.83 billion of revenue in 2016, up from $607 million in 2007. That’s a compound annual growth rate of 23%. Net income has also surged, quintupling over the past 10 years.
27 April, 2017 by The TZ Newswire Staff Comments Off on Cloudera’s IPO: What Investors Need to Know
Cloudera’s IPO: What Investors Need to Know
Another high-growth, money-losing unicorn is entering the public markets soon. This time it’s Cloudera (NYSE: CLDR), which will trade on the NYSE. Cloudera is expected to price after the market closes Thursday. The company looks to sell roughly 15 million shares at $13 per share for a valuation of $1.66 billion, or $2.27 billion when accounting for unexercised restricted stock. Should Foolish investors snap up the goods?
27 April, 2017 by The TZ Newswire Staff Comments Off on Daily Digest 4/27 – Improvised Explosives In Markets, The Housing Bubble Is Back
Daily Digest 4/27 – Improvised Explosives In Markets, The Housing Bubble Is Back
- America is Regressing into a Developing Nation for Most People
- The Housing Bubble Is Back
- Tax Reforms Prioritize Jobs and Industry Over Colossal Debt Burdens
- New home buyers will pay
27 April, 2017 by The TZ Newswire Staff Comments Off on Learn About NinjaTrader’s C# Development Environment in Today’s FREE Training
Learn About NinjaTrader’s C# Development Environment in Today’s FREE Training
The award winning NinjaTrader platform is always FREE TO USE for advanced charting, market analytics, automated strategy development and trade simulation.
FREE Training Event for Thursday, April 27, 2017
Kinetick™ 101 – Real Time and Historical Market Data for Stocks, Futures & Forex
Today at 12:00 PM ET
The following topics…
27 April, 2017 by The TZ Newswire Staff Comments Off on What’s Happening With Johnson & Johnson’s Pharmaceuticals Business?
What’s Happening With Johnson & Johnson’s Pharmaceuticals Business?
Johnson & Johnson‘s (NYSE: JNJ) pharmaceuticals business in on pace to account for half of the company’s sales, and it’s a major source of the company’s earnings. However, the company faces stiffening competition, and that’s forcing J&J to respond with price cuts. Can J&J overcome those headwinds?
27 April, 2017 by The TZ Newswire Staff Comments Off on Cramer: Here’s one thing Trump’s tax plan is not
Cramer: Here’s one thing Trump’s tax plan is not
President Donald Trump’s plan is a tax increase on the wealthy, not a tax cut, Jim Cramer says.
27 April, 2017 by The TZ Newswire Staff Comments Off on Trump’s leaks on torpedoing NAFTA could just be a negotiation tactic
Trump’s leaks on torpedoing NAFTA could just be a negotiation tactic
It’s unclear whether the president is really considering withdrawing from the agreement, Vox reports.